Control Bionics Ltd. (ASX:CBL) Filings

Control Bionics Ltd.

Filings

FilingDateTypeFiled with
Quarterly Activities/Appendix 4C Cash Flow ReportOct 28, 2026Quarterly reportASX
Quarterly Activities/Appendix 4C Cash Flow ReportOct 28, 2026Quarterly reportASX
Medicare Billing Code Secured for NextLevel Speech DevicesAug 26, 2026Operations updateASX
NeuroStrip secures MHRA registrationAug 24, 2026Operations updateASX
US FDA Registration and Device Listing for NeuroStripAug 3, 2026Operations updateASX
Commercial momentum builds across both platform pillarsJul 30, 2026Operations updateASX
Completion of PlacementJun 24, 2026FinancingASX
Pause in TradingJun 23, 2026Trading halt or suspensionASX
Commercial Momentum PresentationJun 3, 2026Operations updateASX
German Statutory Reimbursement Listing for NeuroNodeMar 3, 2026Operations updateASX
Joint venture with NextLevel Assistive TechnologyFeb 25, 2026Acquisition or disposalASX
Half Yearly Report and AccountsFeb 25, 2026Interim reportASX
PRC-Saltillo - Distribution AgreementJan 28, 2026Acquisition or disposalASX
Quarterly Activities/Appendix 4C Cash Flow ReportJan 27, 2026Quarterly reportASX
Tobii Dynavox - Distribution PartnershipJan 26, 2026Operations updateASX
Acquisition of Full Ownership of Neuro Elite AthleticsDec 2, 2025Acquisition or disposalASX
Placement to Raise $3.25 millionDec 1, 2025FinancingASX
Control Bionics Integrates with Apple BCI ProtocolNov 11, 2025Operations updateASX
Rights Issue Offer BookletSep 3, 2025Offer documentASX
Preliminary Final ReportAug 28, 2025ResultsASX
Non-Renounceable Rights IssueAug 27, 2025FinancingASX
FY25 Trading Update and NeuroStrip ProgressJun 12, 2025Other filingsASX
Private PlacementFeb 24, 2025FinancingASX
First Half FY25 Business UpdateDec 16, 2024ResultsASX
Expansion into US Sports and Japanese Rehab MarketsDec 15, 2024Operations updateASX
Coffee Microcaps Meeting PresentationNov 7, 2024Other filingsASX
SIGNIFICANT INCREASE IN REVENUE FROM FASTER NDIS APPROVALSOct 3, 2024ResultsASX
ADDENDUM TO NOTICE OF 2024 AGMSep 27, 2024Other filingsASX
PlacementSep 23, 2024FinancingASX
NON-RENOUNCEABLE RIGHTS ISSUE OFFER AND PRIVATE PLACEMENT ADSep 20, 2024FinancingASX
Non-Renounceable IssueSep 19, 2024Other filingsASX
Investor PresentationSep 19, 2024Other filingsASX
Trading HaltSep 19, 2024Trading halt or suspensionASX
Exclusive UK and Ireland Distribution AgreementSep 8, 2024Acquisition or disposalASX
New US Insurance Code ApprovedAug 18, 2024Operations updateASX
Share placement - North Star Impact Fund to investJul 31, 2024FinancingASX
TGA Approval Granted for DROVE Autonomous Wheelchair ModuleJun 19, 2024Operations updateASX
Control Bionics completes successful $1.04m placementMay 15, 2024FinancingASX
Autonomous Wheelchair Project - US Research AwardJan 23, 2024Operations updateASX
Completion of Placement of Rights Issue ShortfallJan 18, 2024FinancingASX
Rights Issue ResultsNov 29, 2023FinancingASX
Pro rata rights issueOct 29, 2023FinancingASX
Control Bionics Unveils the NeuroStripOct 12, 2023Other filingsASX
Extension to Rights Issue Closing DateJun 13, 2023FinancingASX
DROVE - Presentation at Deakin UniversityApr 18, 2023Other filingsASX
DROVE - Press ReleaseApr 18, 2023Other filingsASX
DROVE - Worlds First Wheelchair Self-drive ControllerApr 17, 2023Other filingsASX
Appointment of CEOJan 19, 2023Management or board changeASX
CEO ResignationSep 14, 2022Other filingsASX
Appendix 4EAug 24, 2022ResultsASX
Monthly Activities/Appendix 4C Cash Flow ReportApr 27, 2022Quarterly reportASX
CBL Enters Japanese Market with NeuroNode TechnologyApr 11, 2022Other filingsASX
Morgans Investment Conference PresentationNov 24, 2021Other filingsASX
Introduction of rental alternative to Australian marketOct 19, 2021Other filingsASX
Appendix 4C - QuarterlyApr 28, 2021Quarterly reportASX
Release of half year results and webinarFeb 22, 2021Interim reportASX
Appendix 4C - quarterlyJan 20, 2021Quarterly reportASX
Voluntary Administration Sale of PFP BusinessJul 4, 2018Other filingsASX
CBL Corporation enters Voluntary AdministrationFeb 25, 2018Other filingsASX
CBI DirectionFeb 19, 2018Other filingsASX
CBL updates the market on AM Best credit rating downgradeFeb 7, 2018Other filingsASX
Suspension from Official QuotationFeb 5, 2018Trading halt or suspensionASX
CBL UPDATES THE MARKET ON FY17 RESULTS EXPECTATIONSFeb 4, 2018Other filingsASX
CBL subsidiary in Luxembourg fined EUR5,000 being appealedJan 2, 2018Other filingsASX
Results Announcement - NZX Appendix 1Aug 23, 2017Other filingsASX
STRONG GROWTH BUT PROFIT IMPACTED BY STRENGTHENING RESERVESAug 17, 2017Operations updateASX
CBL ANNOUNCES IRISH ACQUISITIONJul 10, 2017Acquisition or disposalASX
CBL INSURANCE RETAINS RATING OF A-Jun 12, 2017Other filingsASX
CBL Share Sell-Down To Increase Share Market LiquidityApr 4, 2017Other filingsASX
CBL ANNOUNCES CONDITIONAL AGREEMENT TO BUY US INSURERMar 24, 2017Other filingsASX
CBL Supplementary Information for the 2016 Annual ResultFeb 28, 2017Other filingsASX
CBL Results PresentationFeb 23, 2017Other filingsASX
Focused and consistent strategy sees CBL beat forecastsFeb 23, 2017Other filingsASX
CBL CORPORATION CLOSES NZ$150M STRATEGIC ACQUISITIONJan 5, 2017Acquisition or disposalASX
CBL obtains regulatory approval for SFS AcquisitionOct 10, 2016Acquisition or disposalASX
CBL Corporation completes PlacementSep 29, 2016FinancingASX
CBL Corporation announces equity raisingSep 28, 2016Other filingsASX
CBL Corporation Limited 2016 Half Year ResultsAug 25, 2016Interim reportASX
CBL Corporation plans acquisition of SFSJun 22, 2016Acquisition or disposalASX
CBL announces maiden dividend.Mar 30, 2016DividendASX
Full Year Statutory AccountsFeb 28, 2016Annual reportASX
CBL ANNOUNCES NEW LICENCES IN MEXICOFeb 19, 2016Other filingsASX
CBL delivers clear strategy for Assetinsure Pty LtdFeb 11, 2016Other filingsASX
CBL exercises option to acquire shares from shareholderFeb 10, 2016Acquisition or disposalASX